ArticleCancer management and research2021

Analysis of the Effect of Trastuzumab Combined with Docetaxel on Serum Tumor Markers in the Treatment of HER-2 Positive Breast Cancer and Factors Influencing Therapeutic Efficacy.

Qi-Zhu Feng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.